The V236E APOE3 mutation has been shown to reduce APOE aggregation, enhance APOE lipidation in human brains, and reduce amyloid pathology and neuritic dystrophy in an AD-like mouse model [63]. This evidence concerns the gene APOE and amyloidosis.